Jazz Pharmaceuticals plc buy Royal Bank of Canada
Start price
09.11.23
/
50%
€110.15
Target price
09.11.24
€178.99
Performance (%)
-14.14%
Price
15.07.24
€94.78
Summary
This prediction is currently active. The price of Jazz Pharmaceuticals plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.14%. This prediction currently runs until 09.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 1.870% | 1.870% |
iShares Core DAX® | 0.559% | 3.148% |
iShares Nasdaq 100 | -0.854% | 1.869% |
iShares Nikkei 225® | 1.291% | 4.293% |
iShares S&P 500 | 0.492% | 1.945% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Royal Bank of Canada from $200.00 to $191.00. They now have an "outperform" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.90
29.02.24
29.02.24
€180.57
28.02.25
28.02.25
-13.76%
15.07.24
15.07.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€123.15
10.08.23
10.08.23
€182.37
10.08.24
10.08.24
-23.04%
15.07.24
15.07.24